Seismic Therapeutic to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Seismic Therapeutic, Inc. today announced that company management will participate in the following investor conferences:
Stifel 2026 Healthcare Conference
Date: Tuesday, November 10, 2026
Location: New York, NY
Presentation: Jo Viney, CEO, 10:00am – 10:30am
Format: Company presentation and 1x1 meetings
Guggenheim 3rd Annual Healthcare Innovation Conference
Date: Wednesday, November 11, 2026
Location: Boston, MA
Format: 1x1 meetings
2026 Jefferies Global Healthcare Conference in London
Date: Monday, November 16 – Wednesday, November 18, 2026
Location: London, United Kingdom
Format: 1x1 meetings
In addition, members of the Seismic Therapeutic management team will also participate in a virtual fireside discussion with BTIG on Monday, November 2, 2026 at 1:00pm ET.
About Seismic Therapeutic
Seismic TherapeuticTM is a clinical-stage biotechnology company making a major shift in how immunology therapies are discovered and developed. The company has a growing preclinical stage best-in-class and first-in-class biologics pipeline, derived from its integrated IMPACT platform, to control dysregulated adaptive immunity and address multiple autoimmune diseases. The company is backed by a strong syndicate of life science investors and is located in the Boston biotechnology hub. For more information, please visit www.seismictx.com and follow us on LinkedIn and on X @Seismic_Tx.
Media Contact:
Kathryn Morris
The Yates Network
kathryn@theyatesnetwork.com
Investor Contact:
Ami Bavishi or Nick Colangelo
Gilmartin Group LLC
seismictx@gilmartinir.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
